Skip to main content
Top
Published in: Trials 1/2016

Open Access 01-12-2016 | Study protocol

Comparing glycaemic benefits of Active Versus passive lifestyle Intervention in kidney Allograft Recipients (CAVIAR): study protocol for a randomised controlled trial

Authors: Joanne Wilcox, Chantelle Waite, Lyndsey Tomlinson, Joanne Driscoll, Asra Karim, Edward Day, Adnan Sharif

Published in: Trials | Issue 1/2016

Login to get access

Abstract

Background

Lifestyle modification is widely recommended to kidney allograft recipients post transplantation due to the cardiometabolic risks associated with immunosuppression including new-onset diabetes, weight gain and cardiovascular events. However, we have no actual evidence that undertaking lifestyle modification protects from any adverse outcomes post transplantation. The aim of this study is to compare whether a more proactive versus passive interventional approach to modify lifestyle is associated with superior outcomes post kidney transplantation.

Methods/design

We designed this prospective, single-centre, open-label, randomised controlled study to compare the efficacy of active versus passive lifestyle intervention for kidney allograft recipients early post transplantation. A total of 130 eligible patients, who are stable, nondiabetic and between 3 and 24 months post kidney transplantation, will be recruited. Randomisation is being undertaken by random block permutations into passive (n = 65, leaflet guidance only) versus active lifestyle modification (n = 65, supervised intervention) over a 6-month period. Supervised intervention is being facilitated by two dietitians during the 6-month intervention period to provide continuous lifestyle intervention guidance, support and encouragement. Both dietitians are accredited with behavioural intervention skills and will utilise motivational aids to support study recruits randomised to active intervention. The primary outcome is change in abnormal glucose metabolism parameters after 6 months of comparing active versus passive lifestyle intervention. Secondary outcomes include changes in a wide array of cardiometabolic parameters, kidney allograft function and patient-reported outcome measures. Long-term tracking of patients via data linkage to electronic patient records and national registries will facilitate long-term comparison of outcomes after active versus passive lifestyle intervention beyond the 6-month intervention period.

Discussion

This is the first randomised controlled study to investigate the benefits of active versus passive lifestyle intervention in kidney allograft recipients for the prevention of abnormal cardiometabolic outcomes. In addition, this is the first example of utilising behaviour therapy intervention post kidney transplantation to achieve clinically beneficial outcomes, which has potential implications on many spheres of post-transplant care.

Trial registration

This study was registered with the Clinical Trials Registry on 27 August 2014 (ClinicalTrials.org Identifier: NCT02233491).
Literature
1.
go back to reference Yates CJ, Fourlanos S, Hjelmesaeth J, Colman PG, Cohney SJ. New-onset diabetes after kidney transplantation – changes and challenges. Am J Transplant. 2012;12(4):820–8.CrossRefPubMed Yates CJ, Fourlanos S, Hjelmesaeth J, Colman PG, Cohney SJ. New-onset diabetes after kidney transplantation – changes and challenges. Am J Transplant. 2012;12(4):820–8.CrossRefPubMed
2.
go back to reference Howell M, Tong A, Wong G, Craig JC, Howard K. Important outcomes for kidney transplant recipients: a nominal group and qualitative study. Am J Kidney Dis. 2012;60:186–96.CrossRefPubMed Howell M, Tong A, Wong G, Craig JC, Howard K. Important outcomes for kidney transplant recipients: a nominal group and qualitative study. Am J Kidney Dis. 2012;60:186–96.CrossRefPubMed
3.
4.
go back to reference Sharif A, Baboolal K. Risk factors for new onset diabetes after transplantation. Nat Rev Nephrol. 2010;6(7):415–23.CrossRefPubMed Sharif A, Baboolal K. Risk factors for new onset diabetes after transplantation. Nat Rev Nephrol. 2010;6(7):415–23.CrossRefPubMed
5.
go back to reference Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.CrossRefPubMed Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.CrossRefPubMed
6.
go back to reference Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–44.CrossRefPubMed Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–44.CrossRefPubMed
7.
go back to reference Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368(9548):1673–9.CrossRefPubMed Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368(9548):1673–9.CrossRefPubMed
8.
go back to reference Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3:866–975.CrossRefPubMedCentral Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3:866–975.CrossRefPubMedCentral
9.
go back to reference Hecking H, Kainz A, Werzowa J, Haidinger M, Doller D, Tura A, Karaboyas A, Horl W, Wolzt M, Sharif A, Roden M, Moro E, Pacini G, Port F, Saemann M. Glucose metabolism after renal transplantation. Diabetes Care. 2013;36:2763–71.CrossRefPubMedPubMedCentral Hecking H, Kainz A, Werzowa J, Haidinger M, Doller D, Tura A, Karaboyas A, Horl W, Wolzt M, Sharif A, Roden M, Moro E, Pacini G, Port F, Saemann M. Glucose metabolism after renal transplantation. Diabetes Care. 2013;36:2763–71.CrossRefPubMedPubMedCentral
10.
go back to reference Sharif A, Hecking M, de Vries AP, et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant. 2014;14:1992–2000.CrossRefPubMedPubMedCentral Sharif A, Hecking M, de Vries AP, et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant. 2014;14:1992–2000.CrossRefPubMedPubMedCentral
11.
go back to reference Kopple JD. The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure. Am J Clin Nutr. 2005;81:1257–66.PubMed Kopple JD. The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure. Am J Clin Nutr. 2005;81:1257–66.PubMed
12.
go back to reference Sharif A, Moore R, Baboolal K. Influence of lifestyle modifications in renal transplant recipients with postprandial hyperglycemia. Transplantation. 2008;85:353–8.CrossRefPubMed Sharif A, Moore R, Baboolal K. Influence of lifestyle modifications in renal transplant recipients with postprandial hyperglycemia. Transplantation. 2008;85:353–8.CrossRefPubMed
13.
go back to reference Michie S, Ashford S, Sniehotta FF, Dombrowski SU, Bishop A, French DP. A refined taxonomy of behaviour change techniques to help people change their physical activity and healthy eating behaviours: The CALO-RE Taxonomy. Psychol Health. 2011;26:1479–98.CrossRefPubMed Michie S, Ashford S, Sniehotta FF, Dombrowski SU, Bishop A, French DP. A refined taxonomy of behaviour change techniques to help people change their physical activity and healthy eating behaviours: The CALO-RE Taxonomy. Psychol Health. 2011;26:1479–98.CrossRefPubMed
14.
go back to reference Abraham C, Michie S. A taxonomy of behavior change techniques used in interventions. Health Psychol. 2008;27:379–87.CrossRefPubMed Abraham C, Michie S. A taxonomy of behavior change techniques used in interventions. Health Psychol. 2008;27:379–87.CrossRefPubMed
15.
go back to reference Michie S, Abraham C, Whittington C, McAteer J, Gupta S. Effective techniques in healthy eating and physical activity interventions: a meta-regression. Health Psychol. 2009;28:690–701.CrossRefPubMed Michie S, Abraham C, Whittington C, McAteer J, Gupta S. Effective techniques in healthy eating and physical activity interventions: a meta-regression. Health Psychol. 2009;28:690–701.CrossRefPubMed
16.
go back to reference Ashford S, Edmunds J, French DP. What is the best way to change self-efficacy to promote lifestyle and recreational physical activity? A systematic review with meta-analysis. Br J Health Psychol. 2010;15:265–88.CrossRefPubMed Ashford S, Edmunds J, French DP. What is the best way to change self-efficacy to promote lifestyle and recreational physical activity? A systematic review with meta-analysis. Br J Health Psychol. 2010;15:265–88.CrossRefPubMed
17.
go back to reference Dombrowski SU, Sniehotta FF, Avenell A, Johnston M, MacLennan G, Araújo-Soares V. Identifying active ingredients in complex behavioural interventions for obese adults with obesity-related co-morbidities or additional risk factors for co-morbidities: a systematic review. Health Psychology Review. 2012;6:7–32.CrossRef Dombrowski SU, Sniehotta FF, Avenell A, Johnston M, MacLennan G, Araújo-Soares V. Identifying active ingredients in complex behavioural interventions for obese adults with obesity-related co-morbidities or additional risk factors for co-morbidities: a systematic review. Health Psychology Review. 2012;6:7–32.CrossRef
18.
go back to reference Carver CS, Scheier MF. On the self-regulation of behaviour. New York: Cambridge University Press; 1998.CrossRef Carver CS, Scheier MF. On the self-regulation of behaviour. New York: Cambridge University Press; 1998.CrossRef
19.
go back to reference Dansereau DF, Simpson DD. A picture is worth a thousand words: the case for graphic representations. Professional Psychology: Research and Practice. 2009;40:101–10. Dansereau DF, Simpson DD. A picture is worth a thousand words: the case for graphic representations. Professional Psychology: Research and Practice. 2009;40:101–10.
20.
go back to reference Georgiou G, Webb K, Griggs K, Copello A, Neuberger J, Day E. First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation. Liver Transpl. 2003;9:772–5.CrossRefPubMed Georgiou G, Webb K, Griggs K, Copello A, Neuberger J, Day E. First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation. Liver Transpl. 2003;9:772–5.CrossRefPubMed
23.
go back to reference Cleemput I, Kesteloot K, Moons P, et al. The construct and concurrent validity of the EQ-5D in a renal transplant population. Value Health. 2004;7:499–509.CrossRefPubMed Cleemput I, Kesteloot K, Moons P, et al. The construct and concurrent validity of the EQ-5D in a renal transplant population. Value Health. 2004;7:499–509.CrossRefPubMed
24.
go back to reference Richter P, Werner J, Heerlien A, et al. On the validity of the Beck Depression Inventory: a review. Psychopathology. 1998;31:160–8.CrossRefPubMed Richter P, Werner J, Heerlien A, et al. On the validity of the Beck Depression Inventory: a review. Psychopathology. 1998;31:160–8.CrossRefPubMed
25.
go back to reference Guay F, Vallerand RJ, Blanchard C. On the assessment of situational intrinsic and extrinsic motivation: the Situational Motivation Scale (SMS). Motiv Emot. 2000;24:175–213.CrossRef Guay F, Vallerand RJ, Blanchard C. On the assessment of situational intrinsic and extrinsic motivation: the Situational Motivation Scale (SMS). Motiv Emot. 2000;24:175–213.CrossRef
26.
go back to reference American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care. 2015;38 Suppl:S8–S16. American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care. 2015;38 Suppl:S8–S16.
27.
go back to reference Sharif A, Ravindran V, Moore R, Dunseath G, Luzio S, Owens D, Baboolal K. Insulin resistance indexes in renal transplant recipients on tacrolimus as a primary immunosuppressant. Transplantation. 2010;89:327–33.CrossRefPubMed Sharif A, Ravindran V, Moore R, Dunseath G, Luzio S, Owens D, Baboolal K. Insulin resistance indexes in renal transplant recipients on tacrolimus as a primary immunosuppressant. Transplantation. 2010;89:327–33.CrossRefPubMed
28.
go back to reference Sharif A, Ravindran V, Dunseath G, Luzio S, Owens D, Baboolal K. Predicting hyperglycemia in normoglycemic renal transplant recipients. Transplantation. 2010;89:1341–6.CrossRefPubMed Sharif A, Ravindran V, Dunseath G, Luzio S, Owens D, Baboolal K. Predicting hyperglycemia in normoglycemic renal transplant recipients. Transplantation. 2010;89:1341–6.CrossRefPubMed
29.
go back to reference Sharif A, Ravindran V, Moore R, Dunseath G, Luzio S, Owens D, Baboolal K. The effect of rosuvastatin on insulin sensitivity and pancreatic beta cell function in non-diabetic renal transplant recipients. Am J Transplant. 2009;9:1439–45.CrossRefPubMed Sharif A, Ravindran V, Moore R, Dunseath G, Luzio S, Owens D, Baboolal K. The effect of rosuvastatin on insulin sensitivity and pancreatic beta cell function in non-diabetic renal transplant recipients. Am J Transplant. 2009;9:1439–45.CrossRefPubMed
30.
go back to reference Grave RD, Calugi S, Centis E, Marzocchi R, El Ghoch M, Marchesini G. Lifestyle modification in the management of the metabolic syndrome: achievements and challenges. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2010;3:373–85.CrossRef Grave RD, Calugi S, Centis E, Marzocchi R, El Ghoch M, Marchesini G. Lifestyle modification in the management of the metabolic syndrome: achievements and challenges. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2010;3:373–85.CrossRef
31.
go back to reference Schipper K, Abma TA, Koops C, et al. Sweet and sour after renal transplantation: a qualitative study about the positive and negative consequences of renal transplantation. Br J Health Psychol. 2013;19:580–91.CrossRefPubMed Schipper K, Abma TA, Koops C, et al. Sweet and sour after renal transplantation: a qualitative study about the positive and negative consequences of renal transplantation. Br J Health Psychol. 2013;19:580–91.CrossRefPubMed
32.
go back to reference Segatto BL, Sabiston CM, Harvey WJ, et al. Exploring relationships among distress, psychological growth, motivation and physical activity among transplant recipients. Disabil Rehabil. 2013;35:2097–103.CrossRefPubMed Segatto BL, Sabiston CM, Harvey WJ, et al. Exploring relationships among distress, psychological growth, motivation and physical activity among transplant recipients. Disabil Rehabil. 2013;35:2097–103.CrossRefPubMed
Metadata
Title
Comparing glycaemic benefits of Active Versus passive lifestyle Intervention in kidney Allograft Recipients (CAVIAR): study protocol for a randomised controlled trial
Authors
Joanne Wilcox
Chantelle Waite
Lyndsey Tomlinson
Joanne Driscoll
Asra Karim
Edward Day
Adnan Sharif
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Trials / Issue 1/2016
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-016-1543-6

Other articles of this Issue 1/2016

Trials 1/2016 Go to the issue